article thumbnail

Investment fuels AI-driven development of breakthrough genomic medicines

pharmaphorum

Genomic medicine is a rapidly growing space in which researchers use the information in a person’s genes to identify and administer medical treatment.”. The evolving field of genomic medicine. There are two components to genomic medicine, known as the payload and the vector.

Medicine 105
article thumbnail

Driving clinical trial innovation forward with precision medicine

pharmaphorum

Late last year, pharmaphorum spoke with AstraZeneca’s Ben Challis, VP and head of translational science and experimental medicine, cardiovascular, renal, and metabolism (CVRM), together with Magnus Jörnten-Karlsson, executive director of Unify.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

After splashing $1B, Roche returns lagging cancer drug Gavreto to Blueprint Medicines

Fierce Pharma

After splashing $1B, Roche returns lagging cancer drug Gavreto to Blueprint Medicines aliu Thu, 02/23/2023 - 11:14

Medicine 220
article thumbnail

Crossed wires? Mixed messages on medicines

pharmaphorum

Leela Barham argues that the latest operational guidance for the NHS in England continues to illustrate a disconnect between the messages in big-ticket policy documents from the central government and the messages from the NHS in England on medicines.

Medicine 105
article thumbnail

Overcoming obstacles in digital medicine

MedCity News

A panel discussion on the future of digital medicine highlighted some of the collaborations taking place between pharma companies and digital health, as well as some of the challenges facing the push towards mainstream implementation.

article thumbnail

Breaking through the forecasting fog – 3 trends that will impact critical medicine supply in 2023

pharmaphorum

So, here are three “best guesses” for what 2023 will hold for the off-patent medicines segment — which accounts for roughly 70% of medicines prescribed worldwide (including the vast majority of system-critical antibiotics and ICU therapies), but only about 20% of the total cost.

Medicine 105
article thumbnail

Is digital the future of medicine?

World of DTC Marketing

Digital medicine has been thrust into the spotlight because of the pandemic and the media hype is in overdrive. A study of some 16m American ones just reported in jama Internal Medicine , a journal, found that their use of telemedicine surged 30-fold between January and June.

Medicine 201
article thumbnail

Innovative Medicines Fund and the opportunity for ICSs to mobilise NICE approvals

pharmaphorum

In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination.

Medicine 122
article thumbnail

Zimmer Biomet Expands Sports Medicine Portfolio with $275M Acquisition Announcement

MedCity News

Zimmer Biomet pursued the deal to grow its sports medicine portfolio and gain entry into the high-growth rotator cuff augmentation submarket, an executive said. Daily Devices & Diagnostics Health Tech SYN Top Story acquistion Embody orthopedics sports medicine Zimmer Biomet

Medicine 101
article thumbnail

GSK, J&J, and AZ head this year’s access to medicines ranking

pharmaphorum

The 2022 edition of the Access to Medicine Index (ATMI) – which places the top 20 pharma companies for their efforts to improve delivery of medicines to lower income countries – sees GSK retain the number one position, newly joined by Johnson & Johnson in second and AstraZeneca in third.

Medicine 105
article thumbnail

Call to arms as UK falls back in medicines manufacturing

pharmaphorum

Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition. The post Call to arms as UK falls back in medicines manufacturing appeared first on.

article thumbnail

Eureka Institute to show what translational medicine can do for digital health

pharmaphorum

The Eureka Institute, a Syracuse, Italy-based non-profit, is focused on addressing this disparity by providing education, research, and advocacy around the field of translational medicine. Translational medicine and digital health.

Medicine 111
article thumbnail

How Employers Can Support the Food as Medicine Movement

MedCity News

The Food as Medicine movement has received a lot of interest from payers and health systems recently. Consumer / Employer Daily SYN Top Story Alight food as medicine food insecurity nutrition

Food 95
article thumbnail

Analytical platform could advance mRNA medicine QC

European Pharmaceutical Review

Tokyo researchers have developed a new analytical platform based on liquid chromatography, mass spectrometry and software analysis that quantifies the structure of messenger RNA (mRNA)-based medicines.

article thumbnail

Parallel import of medicinal products: regulatory update

European Pharmaceutical Review

Parallel import of medicinal products is one of the basic and admissible forms of international trade in the European Union (EU) market, based on the principle of free movement of goods established by the Treaty on the Functioning of the European Union.

article thumbnail

AstraZeneca and Sanofi win big as Europe's human medicines committee endorses approvals, label expansions

Fierce Pharma

AstraZeneca and Sanofi win big as Europe's human medicines committee endorses approvals, label expansions. fkansteiner. Mon, 11/14/2022 - 08:59

Medicine 195
article thumbnail

Medicinal cannabis: the route to good manufacturing practice registration

European Pharmaceutical Review

The UK medicinal cannabis sector has witnessed important regulatory advances in recent years. Advising companies, he emphasised that those “manufacturing cannabis-based medicines should not underestimate the scale of the challenge.”

Medicine 122
article thumbnail

Halting Europe’s essential medicines manufacturing exodus

European Pharmaceutical Review

While manufacturers in Europe have contingency plans in place to avoid major disruptions of critical medicines, COVID-19 caused global supplies to dwindle due to the direct impact of pandemic lockdown measures in China and India.

article thumbnail

Bayer, Hua Medicine snag first-in-class nod in China for Roche castoff diabetes drug, but commercial value uncertain

Fierce Pharma

Bayer, Hua Medicine snag first-in-class nod in China for Roche castoff diabetes drug, but commercial value uncertain. Mon, 10/10/2022 - 10:12

Medicine 258
article thumbnail

FDA Publishes Guidance on Regenerative Medicine Therapies

PharmaTech

The new draft guidance describes a standards recognition program for regenerative medicine therapies.

article thumbnail

Sanofi makes low-cost medicines pledge for low-income countries

pharmaphorum

Sanofi has said it will make 30 of its most commonly prescribed medicines available at non-profit prices to 40 lower-income countries, as part of a global health initiative launched by the company last year.

Medicine 119
article thumbnail

Teva says medicines access at risk in Northern Ireland

pharmaphorum

The North Ireland Protocol has been a source of tension between the UK and EU since it came into force at the start of 2021 – and according to one pharma company the end of the so-called ‘grace period’ could result in major issues with medicines supply.

Medicine 105
article thumbnail

Scottish Medicines Consortium recommends Merck’s Tepmetko

PharmaTimes

Therapy is the first oral MET inhibitor treatment option for certain advanced NSCLC adult patients

Medicine 106
article thumbnail

Prime Medicine spells out IPO plans for ‘word processor’ of gene editing

MedCity News

Prime Medicine likens its gene-editing technology to a word processor that searches for the correct place in the genome to make an edit, replacing or repairing a wide variety of target DNA.

Medicine 116
article thumbnail

Battling breast cancer with precision medicine

pharmaphorum

The post Battling breast cancer with precision medicine appeared first on. Partner content Patients Press releases breast cancer Oncology patient centricity patient journey precision medicineImage: Laura Holmes Haddad.

article thumbnail

Lack of medicines in Greece and the solution of Generics

Pharmatutor

Lack of medicines in Greece and the solution of Generics. admin. Tue, 01/10/2023 - 15:46. Georgios-Marios Bolmpasis. MPharm Student University of Athens. Vice President of Pharmacy Students Association(Athens

Medicine 105
article thumbnail

CARsgen and Huadong Medicine to commercialise CT053 in mainland China

Pharmaceutical Technology

CARsgen Therapeutics has announced a col labor ation with Huadong Medicine to commercialise zevorcabtagene autoleucel (zevor-cel), CT053, in mainland China. Under the collaboration, Huadong Medicine will have the exclusive right to commercialise CARsgen’s CT053 in mainland China.

article thumbnail

The Silver Lining Of Innovation in Genetic Medicine

PharmExec

Failed efforts do not overshadow field’s progress, resolve.

Medicine 132
article thumbnail

Roche Terminates Cancer Treatment Pact With Blueprint Medicines

PharmExec

Blueprint Medicines Corporation will regain global commercialization and development rights to Gavreto (pralsetinib).

article thumbnail

mRNA therapeutics: a limitless revolution in medicine

European Pharmaceutical Review

Advances in mRNA technologies and cellular delivery systems coupled with their cost effectiveness, manufacturing simplicity and ability to target previously-undruggable pathways has limitless potential that could revolutionise medicine.

article thumbnail

UK Withdraws Pholcodine-Containing Cough and Cold Medicines

Pharma Leaders

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has withdrawn all pholcodine-containing cough and cold medicines in the UK market as a precautionary measure following a review that the benefits do not outweigh the risk — though rare — of anaphylaxis from the opioid products.

article thumbnail

Lilly and ProQR to expand genetic medicine development agreement

Pharmaceutical Technology

Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. The post Lilly and ProQR to expand genetic medicine development agreement appeared first on Pharmaceutical Technology.

Medicine 131
article thumbnail

Real-word health data firm launches with backing from WashU Medicine, BJC HealthCare

MedCity News

Health data company CuriMeta launched on Tuesday and announced the close of a $6 million seed funding round led by its two institutional partners, BJC HealthCare and the Washington University School of Medicine.

Medicine 107
article thumbnail

LifeArc and MRC launch toolkit to navigate medicines repurposing

PharmaTimes

Medicines repurposing offers new avenues for treating a range of common and rare diseases

article thumbnail

Everest Medicines Begins Operations at mRNA Facility

Pharmaceutical Commerce

Following numerous successful trial runs, vaccine production is expected to reach 700 million.

article thumbnail

NHS England trials first medicine deliveries by drone

pharmaphorum

Using drones will cut the transit time for the medicines from four hours to 30 minutes, and will also require less fuel – an increasingly important consideration as prices rocket at petrol pumps. The post NHS England trials first medicine deliveries by drone appeared first on.

Medicine 105
article thumbnail

EMA Recommends Eleven New Medicines

PharmaTech

The agency’s human medicines committee recommended drugs to treat breast cancer, lupus nephritis, type 2 diabetes and more.

article thumbnail

Putting complex medicines under the microscope

European Pharmaceutical Review

A new wave of medicines has emerged in recent years to supplement the well-established small and large molecule platforms that have historically dominated the market. Complex medicines offer diverse therapeutic modalities, including RNA therapeutics and antibody-drug conjugates (ADCs).

article thumbnail

Innovative Medicines Fund and the opportunity for ICSs-industry collaboration to mobilise NICE approvals

pharmaphorum

In June 2022, NHS England (NHSE) and the National Institute for Health and Care Excellence (NICE) launched the Innovative Medicines Fund (IMF). It builds on the Cancer Drugs Fund (CDF), an early access mechanism for many cancer medicines in England.

article thumbnail

QurAlis raises funds to develop neurodegenerative disease medicines

Pharma Leaders

The financing round, which brings the total funds raised by the firm to $143.5m, was led by EQT Life Sciences, investing from Droia Ventures, Sanofi Ventures and the The post QurAlis raises funds to develop neurodegenerative disease medicines appeared first on Pharmaceutical Business review.